Protocol Ledger

NCT06753916 · Phase II · RECRUITING

ExCrossV Multi Site Trial for Vascularized High Risk Keratoplasty

Interventional Phase II clinical trial protocol NCT06753916 sponsored by Massachusetts Eye and Ear Infirmary in Ophthalmology and Sensory, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2025-04-01 Enrollment: 96 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06753916
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)96 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06753916
Protocol FieldVerified Registry Value
NCT IdentifierNCT06753916
Consolidated Lead SponsorMassachusetts Eye and Ear Infirmary
Therapeutic Condition CohortOphthalmology and Sensory
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment96 participants (ESTIMATED)
Registered Start Date2025-04-01
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Ophthalmology and Sensory Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI